Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose transporter 1 (GLUT1), also known as SLC2A1, is an integral membrane protein responsible for the facilitated diffusion of glucose and other hexoses across the plasma membranes of mammalian cells. It is a member of the solute carrier family 2 (SLC2), specifically classified as a Class I glucose transporter. GLUT1 ensures adequate supply of glucose to energy-demanding organs and supports embryonic development by regulating nutrient transfer. Mutations or deficiencies in GLUT1 cause Glut1 Deficiency Syndrome. Altered expression or function has implications for cancer metabolism and diabetes complications.
Facilitated diffusion via alternating conformation model, sodium-independent
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose transporter 1 (GLUT1).